DE3461093D1 - Synthetic polypeptides corresponding to portions of proteinoids translated from brain-specific mrnas, receptors, methods and diagnostics using the same - Google Patents

Synthetic polypeptides corresponding to portions of proteinoids translated from brain-specific mrnas, receptors, methods and diagnostics using the same

Info

Publication number
DE3461093D1
DE3461093D1 DE8484304747T DE3461093T DE3461093D1 DE 3461093 D1 DE3461093 D1 DE 3461093D1 DE 8484304747 T DE8484304747 T DE 8484304747T DE 3461093 T DE3461093 T DE 3461093T DE 3461093 D1 DE3461093 D1 DE 3461093D1
Authority
DE
Germany
Prior art keywords
proteinoids
diagnostics
receptors
translated
brain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8484304747T
Other languages
English (en)
Inventor
J Gregor Sutcliffe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Clinic and Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic and Research Foundation filed Critical Scripps Clinic and Research Foundation
Application granted granted Critical
Publication of DE3461093D1 publication Critical patent/DE3461093D1/de
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G01N33/567—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds utilising isolate of tissue or organ as binding agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/686—Anti-idiotype
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE8484304747T 1983-07-21 1984-07-11 Synthetic polypeptides corresponding to portions of proteinoids translated from brain-specific mrnas, receptors, methods and diagnostics using the same Expired DE3461093D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51613683A 1983-07-21 1983-07-21

Publications (1)

Publication Number Publication Date
DE3461093D1 true DE3461093D1 (en) 1986-12-04

Family

ID=24054282

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484304747T Expired DE3461093D1 (en) 1983-07-21 1984-07-11 Synthetic polypeptides corresponding to portions of proteinoids translated from brain-specific mrnas, receptors, methods and diagnostics using the same

Country Status (9)

Country Link
EP (1) EP0135277B1 (de)
JP (1) JPS60190796A (de)
KR (1) KR850000920A (de)
AT (1) ATE23169T1 (de)
AU (1) AU576508B2 (de)
CA (1) CA1247521A (de)
DE (1) DE3461093D1 (de)
ES (1) ES534510A0 (de)
PH (2) PH21409A (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL79881A (en) * 1985-08-28 1995-12-08 Pieczenik George Populations of random coding series of oligonucleotides and peptides
US5866363A (en) * 1985-08-28 1999-02-02 Pieczenik; George Method and means for sorting and identifying biological information
EP0297585A3 (de) * 1987-07-01 1990-05-23 Sloan-Kettering Institute For Cancer Research Neuronales Polypeptid und Verfahren zu seiner Herstellung und Verwendung
FR2660757B1 (fr) * 1990-04-06 1994-05-27 Immunotech Sa Procede d'identification ou de dosage de proteines et applications.
US6743892B1 (en) 1995-09-11 2004-06-01 La Jolla Cancer Research Foundation Molecules that home to a selected organ in vivo
US6068829A (en) * 1995-09-11 2000-05-30 The Burnham Institute Method of identifying molecules that home to a selected organ in vivo
DE69637395T2 (de) * 1995-09-11 2008-12-18 La Jolla Cancer Research Foundation, La Jolla Moleküle, die sich in ausgewählten Organen oder Geweben in-vivo einfinden
US6576239B1 (en) 1996-09-10 2003-06-10 The Burnham Institute Angiogenic homing molecules and conjugates derived therefrom
US6232287B1 (en) 1998-03-13 2001-05-15 The Burnham Institute Molecules that home to various selected organs or tissues
US7544767B2 (en) 2002-04-05 2009-06-09 Burnham Institute For Medical Research HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells
US8176811B2 (en) * 2004-07-30 2012-05-15 Dana Heavy Vehicle Systems Group, Llc Ribbed cover for drive axle housing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3949064A (en) * 1973-10-26 1976-04-06 Baxter Laboratories, Inc. Method of detecting antigens or antibodies
US4205057A (en) * 1978-01-17 1980-05-27 Government Of The United States Cerebrospinal fluid protein fragments

Also Published As

Publication number Publication date
PH22909A (en) 1989-01-24
ATE23169T1 (de) 1986-11-15
ES8507612A1 (es) 1985-09-16
JPS60190796A (ja) 1985-09-28
AU3081384A (en) 1985-01-24
CA1247521A (en) 1988-12-28
EP0135277B1 (de) 1986-10-29
ES534510A0 (es) 1985-09-16
AU576508B2 (en) 1988-09-01
EP0135277A1 (de) 1985-03-27
KR850000920A (ko) 1985-03-14
PH21409A (en) 1987-10-15

Similar Documents

Publication Publication Date Title
DE3881801D1 (de) Menschliche somatomedin-traeger-protein-untereinheiten und verfahren zu ihrer herstellung.
DE3461093D1 (en) Synthetic polypeptides corresponding to portions of proteinoids translated from brain-specific mrnas, receptors, methods and diagnostics using the same
HU9303023D0 (en) Peptide nucleicadis and method for producing them
EP0318554A4 (de) Multifunktionelle proteine mit vorbestimmter zielsetzung.
IL126044A0 (en) Engineering affinity ligands for macromolecules
DE69034269D1 (de) Neues Verfahren zur Erschliessung des immunologischen Repertoirs
ATE283916T1 (de) Menschliche metabotropische glutamatrezeptor untertype hmglur7 und verwandte dns-verbindungen
ATE123780T1 (de) Verfahren zur verwendung und herstellung von peptiden.
DE69000125D1 (de) Verfahren zum verbinden von elementen zur herstellung von teilen aus mehrstrukturellem verbundmaterial.
ATE112311T1 (de) Bindeproteine für insulinähnliche wachstumsfaktoren.
DE3775618D1 (de) Verfahren zur herstellung von toner durch suspensionspolymerisation.
DE3871260D1 (de) Partielles abbauprodukt von proteinen, verfahren zu seiner herstellung und seine verwendung.
DE3751747D1 (de) Verfahren zum Herstellen von Briketts aus gebrannten Pellets
CS671788A2 (en) Method of hydrocarbon spraying raw materials
IL122233A0 (en) Monoclonal antibodies their production and pharmaceutical compositions and diagnostic reagents containing them
ATE186781T1 (de) Verfahren zur herstellung von testelementen
EP0257778A3 (en) Apolipoprotein b-specific monoclonal antibodies produced by two novel hybridomas
DE3581288D1 (de) Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.
DE69131056D1 (de) Verfahren zum Modifizieren der Anfärbbarkeit von Polyamiden durch Zuführung von Polyamidflocken
DE3873524D1 (de) Iodierte polymere, verfahren zu ihrer herstellung und ihre verwendung als kontrastmittel.
DE3485711D1 (de) Immunoadsorbens und verfahren zur zurueckgewinnung von vitamin-k-abhaengigen proteinen mittels dieses adsorbens.
DE3482021D1 (de) Verfahren zur erhoehung der milchleistung von milchliefernden kuehen mittels futter, verfahren zur herstellung dieses futters und apparat zur durchfuehrung dieses verfahrens.
ATE216778T1 (de) Verfahren zur herstellung von konjugaten aus einem spezifischen bindungspartner und einem kohlenhydrathaltigen protein
ATA9094A (de) Verfahren zum herstellen von brennmaterial aus biomasse
DE69810959D1 (de) Verfahren zur herstellung von pyrrolamiden

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee